Search results
Principal Scientist - Biopharmaceutics, Merck - Cited by 925 - Oral Drug Delivery - Intestinal Biology - Peptide Drugs - IVIVC.
Research Scientist in Biopharmaceutics at Merck/MSD. I’m an expert in oral drug delivery, permeation enhancers, and intestinal absorption of drugs, nutrients, and cells. PhD at UCD...
2024-06-28 | Journal article. DOI: 10.1021/acs.molpharmaceut.4c00210. Contributors : John P. Gleeson; Stephanie Y. Zhang; Natalia Subelzu; Jing Ling; Becky Nissley; Whitney Ong; Rebecca Nofsinger; Filippos Kesisoglou. Show more detail.
May 8, 2017 · J. P. Gleeson. First published: 08 May 2017. https://doi.org/10.1111/nbu.12260. Citations: 16. Read the full text. PDF. Tools. Share. Abstract. The majority of dietary nutrient absorption occurs in the small intestine, with the intestinal epithelium acting as a barrier to the contents of the intestinal lumen.
View John Gleeson PhD’s profile on LinkedIn, a professional community of 1 billion members. I’m an experience drug delivery scientist and a subject matter expert in Intestinal…
- Merck
John Patrick Gleeson. Post-Doctorate. Senior Researcher. Merck & Co., Inc. Kenilworth, United States. John Gleeson. Overview.
John P Gleeson's 40 research works with 2,163 citations and 11,126 reads, including: An Innovative miR‐Activated Scaffold for the Delivery of a miR‐221 Inhibitor to Enhance Cartilage...
